Indication

Chronic Hepatitis B and Hepatitis D Co-infection

1 clinical trial

1 product

Clinical trial

An Open-label Phase IIa Study to Evaluate the Antiviral Effect and Safety of HH-003 Injection in Subjects With Chronic Hepatitis B and D Co-infection

Status: Terminated, Estimated PCD: 2022-07-25

Product